Welcome to our dedicated page for Venus Concept news (Ticker: VERO), a resource for investors and traders seeking the latest updates and insights on Venus Concept stock.
Overview
Venus Concept Inc is a global medical technology company specializing in the development, commercialization, and delivery of minimally invasive and non-invasive medical aesthetic and hair restoration technologies. Utilizing industry-specific methodologies, the company is renowned for its innovative subscription model, which uniquely pairs cutting-edge aesthetic systems with comprehensive business support designed to empower both emerging and established practices.
Business Model & Value Proposition
At its core, Venus Concept Inc not only provides advanced medical aesthetic devices but also redefines how aesthetic practices engage with technology through its subscription-based business model. This model integrates an extensive warranty program, unmatched marketing support, continuous clinical education, and practice enhancement programs. The seamless coupling of state-of-the-art technological platforms with a unique service-centric approach enables aesthetic professionals to leverage both equipment and business insights, setting a new benchmark in the medical aesthetics industry.
Product & Technology Portfolio
The company offers a broad portfolio of aesthetic systems and related solutions that address a wide range of cosmetic and dermatological challenges. Its product offerings encompass devices for skin, body, and hair restoration treatments. With a focus on non-invasive and minimally invasive procedures, each device is designed to deliver precise, effective treatments that enhance skin tone, tighten texture, and improve overall appearance. Venus Concept Inc's technology platforms incorporate advanced features such as Intense Pulsed Light (IPL), NanoFractional Radio Frequency, and proprietary technologies that blend multiple energy modalities for comprehensive treatment results.
Market Position & Global Reach
Venus Concept Inc has established itself as a key player within the global medical aesthetics market. With operations spanning over 60 countries and a significant presence in its primary revenue market, the United States, the company has built a robust international distribution network. This global footprint is supported by strategic partnerships and rigorous regulatory certifications that underpin its status in various lucrative markets.
Industry Differentiators
- Unique Subscription Model: The company is the first in its industry to offer a true subscription service, providing essential practice support and a suite of comprehensive benefits.
- Technological Innovation: Its diverse portfolio integrates multiple advanced treatment modalities, ensuring that practitioners have access to best-in-class aesthetic solutions.
- Comprehensive Support Services: Beyond technology, Venus Concept Inc enhances the customer experience through extensive warranty programs, ongoing clinical education, and marketing support that collectively reduce barriers to success in the competitive aesthetics landscape.
Operational Excellence & Support Ecosystem
The company's operational strategy is centered on fostering long-term clinical and business success. By offering continuous education and practice enhancement programs, Venus Concept Inc ensures that aesthetic professionals are equipped with the latest industry knowledge and technical training. This robust support ecosystem helps practices optimize their operations while maintaining high standards of patient care.
Competitive Landscape & Positioning
While the medical aesthetics market is highly competitive, Venus Concept Inc differentiates itself through its dual emphasis on technological innovation and an inclusive service model. The combination of high-performance aesthetic systems with an industry-exclusive subscription model provides a competitive edge that addresses both clinical outcomes and business efficiency. This comprehensive approach positions the company as not only a supplier of medical devices but also a strategic partner in facilitating practice growth and operational excellence.
Conclusion
In summary, Venus Concept Inc stands out as an innovative force within the global medical aesthetics arena. Its pioneering subscription model, combined with a rich array of minimally invasive and non-invasive treatment technologies, sets a high standard for quality and support in the industry. By consistently integrating advanced medical technologies with a deep commitment to customer success, the company continues to shape the landscape of medical aesthetics, offering clear value to both practitioners and the broader healthcare market.
Venus Concept (NASDAQ: VERO) will announce its second quarter financial results for fiscal year 2021 on August 13, 2021, before market open. A conference call to discuss these results will occur at 8:00 a.m. ET the same day, with a Q&A session to follow. Interested parties may join by dialing 877-407-2991, or view the live webcast on the company's investor relations site. Venus Concept is recognized for its wide range of minimally invasive and non-invasive aesthetic technologies across over 60 countries, supporting a subscription-based sales model in North America.
Venus Concept (NASDAQ: VERO) reported a 56% increase in total revenue for Q1 2021, reaching $22.6 million compared to $14.5 million in Q1 2020. The company's gross margin improved to 67.4% from 64.0%, while the GAAP operating loss significantly decreased to $6.8 million from $43.6 million year-over-year. Adjusted EBITDA loss decreased 63% to $5.0 million. The company revised its 2021 revenue guidance to $100 million to $105 million, an anticipated growth of 28% to 35%.
Venus Concept (NASDAQ: VERO) announced its financial results for Q1 fiscal year 2021 will be released on May 17, 2021, after market close. A conference call is scheduled for the same day at 5:00 PM ET to discuss these results, with participation details provided for both domestic and international callers. The call will also be available via a live webcast and archived for later access. Venus Concept is known for its innovative medical aesthetic technologies, operating in over 60 countries with a subscription-based sales model.
Venus Concept (NASDAQ: VERO) reported Q4 2020 revenue of $25.8 million, down 19% YoY from $31.9 million, impacted by COVID-19. However, it marked a 25% increase from Q3 2020's $20.7 million. The operating loss decreased by 42% YoY to $10.3 million, with a net loss of $15.0 million, improving from $22.7 million in Q4 2019. Adjusted EBITDA loss was $2.4 million, compared to $11.5 million the previous year. For 2021, guidance suggests revenue growth of 26% to 32%, assuming no significant COVID-19 resurgence. Cash stood at $34.4 million as of December 31, 2020.
Venus Concept (NASDAQ: VERO) announced the signing of Venus Williams as the brand ambassador for its Venus Bliss™ product line. CEO Dom Serafino expressed enthusiasm about this partnership, stating Williams represents the company's vision and values. Williams, a highly accomplished athlete and entrepreneur, has a positive public image that aligns with the brand. Venus Concept is a leader in medical aesthetic technology, offering a range of minimally invasive and non-invasive products across over 60 countries.
Venus Concept (NASDA: VERO) announced its participation in major investor conferences in March 2021. The Oppenheimer 31st Annual Healthcare Conference will take place virtually from March 16-18, with management presenting at 3:10 p.m. ET on March 17. They will also participate in the Maxim Emerging Growth Conference on March 17-18, featuring a panel discussion on March 17 at 2:00 p.m. ET. Audio webcasts of these presentations will be available on their investor relations website.
Venus Concept, a leading global medical aesthetic technology firm, announced its participation in the H.C. Wainwright Annual Global Life Sciences Conference on March 9-10, 2021. The company's management will present virtually, with the presentation available on-demand starting March 9 at 7:00 a.m. Eastern Time. The audio webcast can be accessed on the company’s investor relations website, and an archive will be available post-conference. Venus Concept operates in over 60 countries, offering a broad range of minimally invasive aesthetic technologies and hair restoration systems.
Venus Concept, a leader in medical aesthetic technology, announced its participation in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17, 2021, at 10:00 a.m. Eastern Time.
The engagement will feature a virtual fireside chat, accessible via an audio webcast on the Company’s investor relations website. Post-event, an archive of the webcast will be available for replay. Venus Concept specializes in minimally invasive aesthetic technologies and has operations in over 60 countries.
Venus Concept (NASDAQ: VERO) announced that it will release its fourth quarter and fiscal year 2020 financial results after the market closes on March 29, 2021. Management will host a conference call at 5:00 PM ET on the same day to discuss these results, with a question-and-answer session to follow. Participants can join by dialing 877-407-2991 and using access code 13715787. A live webcast will also be available on their investor relations website, with a replay option for those unable to attend.
Venus Concept (NASDAQ: VERO) reported preliminary revenue for Q4 2020, expecting between $25.3M to $26.3M, a decrease of 21% to 24% from Q4 2019. For FY 2020, revenue is projected at $77.5M to $78.5M, declining 36% to 37% year-over-year. Despite challenges from COVID-19, the company anticipates FY 2021 revenue growth of 27% to 31%, estimating between $98M to $103M. The management highlighted a strengthened balance sheet with approximately $30 million in cash, following recent financing activities, which they believe positions the company for future growth.
FAQ
What is the current stock price of Venus Concept (VERO)?
What is the market cap of Venus Concept (VERO)?
What is the core business of Venus Concept Inc?
How does the subscription model benefit aesthetic practices?
What types of technologies does Venus Concept offer?
In which markets does Venus Concept primarily operate?
What sets Venus Concept apart from other competitors in the aesthetics industry?
How does Venus Concept support the clinical success of practitioners?
What role does innovation play in Venus Concept's strategy?
